SS Innovations International, Inc. (NASDAQ: SSII)

SS Innovations International, Inc. is a commercial-stage surgical robotics company that designs manufactures and markets the SSi Mantra Surgical Robotic System for use in urology general gynecology colorectal gastroenterology head and neck thoracic and cardiac surgeries. The company was founded by Dr Sudhir P Srivastava and launched commercial sales of the SSi Mantra in India in late 2022 after receiving regulatory approval from the Central Drugs Standard Control Organization. As of December 31 2025 the company had installed 168 systems across ten countries with 154 systems in India and 14 systems overseas.

We generate revenue from the sale of the SSi Mantra through three models outright purchase purchase on a deferred or installment basis and purchase on a pay per procedure basis. In addition we earn recurring revenue from the sale of instruments accessories and related services. Our systems and related devices are sold directly to customers as well as through a network of distributors.

SS Innovations International, Inc. competes in the global surgical robotics market against established players such as Intuitive Surgical Asensus Surgical CMR Surgical Medtronic and Johnson Johnson. The company differentiates itself by offering a lower cost robotic system that is designed to be affordable and accessible in underserved regions. The SSi Mantra has received regulatory approval in India and in multiple countries including Colombia Ecuador Guatemala Indonesia Kenya Oman Philippines Sri Lanka Ukraine and the United Arab Emirates. The company also holds ISO 13485 certification and an Indian export license that allows it to market its systems in fifty non FDA and non EU countries with only minimal registration required in an additional seventy nine countries. These factors give SS Innovations International, Inc. a competitive advantage in price and geographic reach compared to many of its rivals.

SS Innovations International, Inc. serves hospitals and healthcare facilities that perform surgical procedures in urology general gynecology colorectal gastroenterology head and neck thoracic and cardiac specialties. The company has installed its systems in more than 150 hospitals in India and in a number of overseas locations including sites in the United Arab Emirates Ecuador Iraq Nepal Colombia Indonesia and the Philippines. Specific customers mentioned in the filing include Rajiv Gandhi Cancer Institute Aster CMI Hospital and Johns Hopkins University which has been used for evaluation and training purposes.